These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6185446)

  • 1. The effect of angiotensin converting enzyme inhibition of coronary blood flow and hemodynamics in patients without coronary artery disease.
    Faxon DP; Creager MA; Halperin JL; Sussman HA; Gavras H; Ryan TJ
    Int J Cardiol; 1982; 2(2):251-62. PubMed ID: 6185446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
    Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
    Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
    Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
    Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-angiotensin system inhibition in conscious sodium-depleted dogs. Effects on systemic and coronary hemodynamics.
    Liang CS; Gavras H; Hood WB
    J Clin Invest; 1978 Apr; 61(4):874-83. PubMed ID: 659580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the renin-angiotensin system in blood pressure regulation. The cardiovascular effects of converting enzyme inhibition in normotensive subjects.
    Niarchos AP; Pickering TG; Case DB; Sullivan P; Laragh JH
    Circ Res; 1979 Dec; 45(6):829-37. PubMed ID: 498446
    [No Abstract]   [Full Text] [Related]  

  • 6. Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure.
    De Marco T; Daly PA; Liu M; Kayser S; Parmley WW; Chatterjee K
    J Am Coll Cardiol; 1987 May; 9(5):1131-8. PubMed ID: 3033043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].
    Stumpe KO
    Klin Wochenschr; 1985 Sep; 63(18):897-906. PubMed ID: 2997540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the converting enzyme inhibitor (SQ 20881) on the pulmonary circulation in man.
    Niarchos AP; Roberts AJ; Laragh JH
    Am J Med; 1979 Nov; 67(5):785-91. PubMed ID: 315711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin system inhibition in acute myocardial infarction in dogs. Effects on systemic hemodynamics, myocardial blood flow, segmental myocardial function and infarct size.
    Liang CS; Gavras H; Black J; Sherman LG; Hood WB
    Circulation; 1982 Dec; 66(6):1249-55. PubMed ID: 6183019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of the converting enzyme inhibitor teprotide in normal- and high-renin hypertension.
    Niarchos AP; Pickering TG; Wallace JM; Case DB; Laragh JH
    Clin Pharmacol Ther; 1980 Nov; 28(5):592-601. PubMed ID: 6160013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibition in patients with congestive heart failure.
    Gavras H; Faxon DP; Berkoben J; Brunner HR; Ryan TJ
    Circulation; 1978 Nov; 58(5):770-6. PubMed ID: 699246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibition in congestive heart failure: the concept.
    Cohn JN; Levine TB
    Am J Cardiol; 1982 Apr; 49(6):1480-3. PubMed ID: 6176108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular responses to isometric exercise and standing in normotensive subjects during converting enzyme inhibition with teprotide.
    Niarchos AP; Pickering TG; Laragh JH
    Hypertension; 1982; 4(4):538-44. PubMed ID: 6185419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of angiotensin and angiotensin blockade on coronary circulation and coronary reserve.
    Magrini F; Reggiani P; Roberts N; Meazza R; Ciulla M; Zanchetti A
    Am J Med; 1988 Mar; 84(3A):55-60. PubMed ID: 3064599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of angiotensin converting enzyme and renin inhibition in rats following myocardial infarction.
    Mento PF; Maita ME; Murphy WR; Holt WF; Wilkes BM
    J Cardiovasc Pharmacol; 1993 May; 21(5):791-6. PubMed ID: 7685451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic circulatory adjustments to acute hypoxia and reoxygenation in unanesthetized sheep. Role of renin, angiotensin II, and catecholamine interactions.
    Davidson D; Stalcup SA
    J Clin Invest; 1984 Feb; 73(2):317-28. PubMed ID: 6365971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.
    Case DB; Wallace JM; Keim HJ; Weber MA; Sealey JE; Laragh JH
    N Engl J Med; 1977 Mar; 296(12):641-6. PubMed ID: 190537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between coronary occlusion and the renin-angiotensin system in the dog.
    Ertl G; Alexander RW; Kloner RA
    Basic Res Cardiol; 1983; 78(5):518-33. PubMed ID: 6360140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unrelated responses of brachial artery hemodynamics and renin-angiotensin system to acute converting enzyme inhibition by enalaprilat in essential hypertension.
    Levenson J; Chau NP; Billaud E; Simon A
    Am J Cardiol; 1988 May; 61(13):1056-60. PubMed ID: 2834938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.